School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Satheesh Chonat

  • SOM: Peds: Sickle Cell
    Associate Professor
  • (517) 974-7579
  • satheesh.chonat@emory.edu
  • Children's Healthcare of Atlanta Provider Profile
  • Aflac Cancer & Blood Disorders Center
    Pediatrics
    2015 Uppergate Drive
Head shot of Satheesh Chonat

Academic Appointment

  • Associate Professor of Pediatrics, Emory University

Education

Degrees

  • MD from Ramaiah Medical College

Research

Publications

  • Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programme.
    Br J Haematol
    03/09/2025 Authors: Balciuniene J; Yilmaz S; Chonat S; Grace RF; Soff GA; Ravindranath Y; Glader B; Bianchi P; McGee B; Agarwal AM
  • Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody production.
    J Thromb Haemost Volume: 23 Page(s): 440 - 457
    02/01/2025 Authors: York ES; Dratch BD; Ito J; Horwitz SM; Emamian S; Ambarian JA; Gill S; Jones J; Chonat S; Lollar P
  • CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion.
    Front Immunol Volume: 16 Page(s): 1548548
    01/01/2025 Authors: Jajosky RP; Covington ML; Liu J; Chai L; Zerra PE; Chonat S; Stowell SR; Arthur CM
  • Fatal thrombotic microangiopathy during induction for acute myeloid leukemia: A case report and review of vascular complications in germline GATA2 haploinsufficiency.
    Br J Haematol Volume: 206 Page(s): 368 - 371
    01/01/2025 Authors: Frost EL; Chonat S; Williams KM; Aumann W; Stevenson J; Yin J; Schniederjan M; Arnold S; Schoettler ML
  • Harnessing the potential of red blood cells in immunotherapy.
    Hum Immunol Volume: 85 Page(s): 111084
    11/01/2024 Authors: Jajosky RP; Zerra PE; Chonat S; Stowell SR; Arthur CM
  • Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.
    Am J Hematol Volume: 99 Page(s): 2108 - 2117
    11/01/2024 Authors: Kulasekararaj A; Lanza F; Arvanitakis A; Langemeijer S; Chonat S; Tombak A; Hanes V; Cao J; Miller MJ; Colbert A
  • Real-World Application of Recently Proposed ASTCT/CIBMTR/EBMT/APBMT Consensus Risk Stratification for Transplantation-Associated Thrombotic Microangiopathy in Children.
    Transplant Cell Ther Volume: 30 Page(s): 929.e1 - 929.e6
    09/01/2024 Authors: Schoettler ML; Ofori J; Bryson E; Spencer K; Qayed M; Stenger E; Bidgoli A; Chonat S; Westbrook A; Williams KM
  • Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation-Asecondary CIBMTR analysis.
    Br J Haematol Volume: 205 Page(s): 243 - 255
    07/01/2024 Authors: Schoettler ML; Westbrook A; Watkins B; Stenger E; Qayed M; Chonat S; Williams KM
  • COping with acute sickle cell hemolysis.
    Blood Volume: 143 Page(s): 2452 - 2453
    06/13/2024 Authors: Chonat S; Stowell SR
  • Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuria.
    Blood Adv Volume: 8 Page(s): 2813 - 2824
    06/11/2024 Authors: Chonat S; Kulagin A; Maschan A; Bartels M; Buechner J; Punzalan R; Richards M; Ogawa M; Hicks E; Yu J
  • Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy.
    Blood Adv Volume: 8 Page(s): 1220 - 1233
    03/12/2024 Authors: Schoettler ML; Lehmann L; Kao P-C; Chen N; Jodele S; Chonat S; Williams KM; London WB; Duncan C; Dandoy C
  • Diagnosis and management of pyruvate kinase deficiency: international expert guidelines.
    Lancet Haematol Volume: 11 Page(s): e228 - e239
    03/01/2024 Authors: Al-Samkari H; Shehata N; Lang-Robertson K; Bianchi P; Glenthj A; Sheth S; Neufeld EJ; Rees DC; Chonat S; Kuo KHM
  • D-dimer and sinusoidal obstructive syndrome-novel poor prognostic features of thrombotic microangiopathy in children after hematopoietic cellular therapy in a single institution prospective cohort study.
    Am J Hematol Volume: 99 Page(s): 370 - 379
    03/01/2024 Authors: Schoettler ML; French K; Harris A; Bryson E; Deeb L; Hudson Z; Obordo J; Chandrakasan S; Parikh S; Watkins B
  • Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
    Transplant Cell Ther Volume: 30 Page(s): 336.e1 - 336.e8
    03/01/2024 Authors: Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J
  • Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE-KIDS 1 trial.
    EJHaem Volume: 5 Page(s): 125 - 130
    02/01/2024 Authors: Chonat S; Fields E; Baratz H; Watt A; Pochron M; Dixon S; Tonda M; Brown C; Archer D
  • Frequency of HLA-DR+CD38hi T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders.
    J Allergy Clin Immunol Volume: 153 Page(s): 309 - 319
    01/01/2024 Authors: Nguyen TH; Kumar D; Prince C; Martini D; Grunwell JR; Lawrence T; Whitely T; Chappelle K; Chonat S; Prahalad S
  • Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression.
    Blood Volume: 142 Page(s): 1082 - 1098
    09/21/2023 Authors: Jajosky RP; Patel KR; Allen JWL; Zerra PE; Chonat S; Ayona D; Maier CL; Morais D; Wu S-C; Luckey CJ
  • DARATUMUMAB FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC PATIENTS POST-HEMATOPOIETIC CELL TRANSPLANT
    Volume: 70 Page(s): S214 - S215
    06/01/2023 Authors: Yoo J; Obordo J; Schoettler M; Qayed M; Hughes K; Harris A; Spencer K; Parikh S; Chandrakasan S; Chonat S
  • USE OF CAPLACIZUMAB IN PEDIATRIC THROMBOTIC THROMBOCYTOPENIC PURPURA PATIENTS
    Volume: 70 Page(s): S139 - S139
    06/01/2023 Authors: Graciaa S; Sidonio R; Zerra P; Rollins M; Briones M; Chonat S
  • CLINICAL OUTCOMES OF CHILDREN AND ADOLESCENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Volume: 70 Page(s): S134 - S135
    06/01/2023 Authors: Saleem N; Graciaa S; McElfresh P; Arnold S; Schoettler M; Briones M; Chonat S
  • Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
    Blood Adv Volume: 7 Page(s): 1784 - 1795
    05/09/2023 Authors: Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B
  • Factor H autoantibodies contribute to complement dysregulation in multisystem inflammatory syndrome in children (MIS-C).
    Am J Hematol Volume: 98 Page(s): E98 - E101
    05/01/2023 Authors: Zerra PE; Stowell J; Verkerke H; McCoy J; Jones J; Graciaa S; Lu A; Hussaini L; Anderson EJ; Rostad CA
  • Efficacy and safety of biosimilar ABP 959 compared with reference eculizumab in adults with PNH
    Volume: 201 Page(s): 4 - 5
    04/01/2023 Authors: Kulasekararaj A; Lanza F; Arvanitakis A; Langemeijer S; Chonat S; Pan J; Chow V; Saportas Y; Henary H
  • Storage differentially impacts alloimmunization to distinct red cell antigens following transfusion in mice.
    Transfusion Volume: 63 Page(s): 457 - 462
    03/01/2023 Authors: Maier CL; Jajosky RP; Patel SR; Verkerke HP; Fuller MD; Allen JW; Zerra PE; Fasano RM; Chonat S; Josephson CD
  • Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
    Transplant Cell Ther Volume: 29 Page(s): 45.e1 - 45.e8
    01/01/2023 Authors: Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J
  • Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components.
    Cancer Rep (Hoboken) Volume: 6 Page(s): e1665
    01/01/2023 Authors: Stevenson J; DeGroote NP; Keller F; Brock KE; Bergsagel DJ; Miller TP; Cornwell P; Fasano R; Chonat S; Castellino SM
  • Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thrombocytopenic purpura: A report from a large pediatric hematology center.
    Pediatr Blood Cancer Volume: 69 Page(s): e29992
    12/01/2022 Authors: Graciaa S; Adeagbo S; Fong G; Rollins M; McElfresh P; Zerra PE; Bennett C; Josephson CD; Briones M; Fasano RM
  • Compassionate use narsoplimab to treat transplant associated thrombotic microangiopathy in a pediatric patient with multi-organ failure
    Volume: 57 Page(s): 350 - 350
    11/01/2022 Authors: Schoettler M; Bryson E; Deeb L; Qayed M; Watkins B; Chandrakasan S; Chonat S; Williams K
  • Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial.
    Lancet Haematol Volume: 9 Page(s): e724 - e732
    10/01/2022 Authors: Glenthj A; van Beers EJ; Al-Samkari H; Viprakasit V; Kuo KHM; Galactros F; Chonat S; Porter J; Zagadailov E; Xu R
  • Sustained effect on hemoglobin levels and reduced transfusion burden maintained in patients with pyruvate kinase deficiency on mitapivat in a long-term extension study
    Volume: 45 Page(s): 138 - 139
    09/01/2022 Authors: Grace RF; Glenthoj A; Barcellini W; Verhovsek M; Rothman JA; Morado AM; Layton DM; Andres O; Galacteros F; van Beers EJ
  • A virtuosic CADENZA played by sutimlimab.
    Blood Volume: 140 Page(s): 933 - 935
    09/01/2022 Authors: Chonat S; Stowell SR
  • Evaluating ravulizumab for the treatment of children and adolescents with paroxysmal nocturnal hemoglobinuria.
    Expert Rev Hematol Volume: 15 Page(s): 385 - 392
    05/01/2022 Authors: Yoo JJ; Chonat S
  • Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice.
    Transfusion Volume: 62 Page(s): 948 - 953
    05/01/2022 Authors: Arthur CM; Patel SR; Sharma A; Zerra PE; Chonat S; Jajosky RP; Fasano RM; Patel R; Bennett A; Zhou X
  • Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
    N Engl J Med Volume: 386 Page(s): 1432 - 1442
    04/14/2022 Authors: Al-Samkari H; Galactros F; Glenthj A; Rothman JA; Andres O; Grace RF; Morado-Arias M; Layton DM; Onodera K; Verhovsek M
  • Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency.
    Blood Adv Volume: 6 Page(s): 1844 - 1853
    03/22/2022 Authors: Al-Samkari H; van Beers EJ; Morton DH; Eber SW; Chonat S; Kuo KHM; Kollmar N; Wang H; Breakey VR; Sheth S
  • Risk of Disseminated Gonococcal Infections With Terminal Complement Blockade.
    J Pediatr Hematol Oncol Volume: 44 Page(s): e493 - e495
    03/01/2022 Authors: Graciaa SH; Graciaa DS; Yildirim I; Chonat S
  • T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome.
    Blood Volume: 139 Page(s): 369 - 383
    01/20/2022 Authors: Kumar D; Prince C; Bennett CM; Briones M; Lucas L; Russell A; Patel K; Chonat S; Graciaa S; Edington H
  • Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.
    Haematologica Volume: 107 Page(s): 178 - 186
    01/01/2022 Authors: Hecht A; Meyer JA; Behnert A; Wong E; Chehab F; Olshen A; Hechmer A; Aftandilian C; Bhat R; Choi SW
  • Heme interferes with the regulatory properties of complement factor I in human plasma
    Volume: 141 Page(s): 180 - 181
    01/01/2022 Authors: Gerogianni A; Poillerat V; Dimitrov J; Chonat S; Sandholm K; Ekholt K; Ekdahl KN; Mollnes TETE; Mohlin C; Roumenina L
  • Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation.
    Front Immunol Volume: 13 Page(s): 901876
    01/01/2022 Authors: Gerogianni A; Dimitrov JD; Zarantonello A; Poillerat V; Chonat S; Sandholm K; McAdam KE; Ekdahl KN; Mollnes TE; Mohlin C
  • Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy.
    Curr Opin Hematol Volume: 28 Page(s): 408 - 416
    11/01/2021 Authors: Schoettler M; Chonat S; Williams K; Lehmann L
  • Correction to: T CellEpsteinBarr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in NonAsians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    J Clin Immunol Volume: 41 Page(s): 1979
    11/01/2021 Authors: Shamriz O; Kumar D; Shim J; Briones M; Quarmyne M-O; Chonat S; Lucas L; Edington H; White MH; Mahajan A
  • T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    J Clin Immunol Volume: 41 Page(s): 1582 - 1596
    10/01/2021 Authors: Shamriz O; Kumar D; Shim J; Briones M; Quarmyne M-O; Chonat S; Lucas L; Edington H; White MH; Mahajan A
  • ACTIVATE-T: A PHASE 3, OPEN-LABEL, MULTICENTER STUDY OF MITAPIVAT IN ADULTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
    Volume: 106 Page(s): 30 - 30
    10/01/2021 Authors: Glenthoj A; Van Beers EJ; Al-Samkari H; Viprakasit V; Kuo KHM; Galacteros F; Chonat S; Porter J; Gheuens S; Beynon V
  • Pyruvate kinase deficiency in children.
    Pediatr Blood Cancer Volume: 68 Page(s): e29148
    09/01/2021 Authors: Chonat S; Eber SW; Holzhauer S; Kollmar N; Morton DH; Glader B; Neufeld EJ; Yaish HM; Rothman JA; Sharma M
  • Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice.
    Blood Volume: 138 Page(s): 706 - 721
    08/26/2021 Authors: Zerra PE; Patel SR; Jajosky RP; Arthur CM; McCoy JW; Allen JWL; Chonat S; Fasano RM; Roback JD; Josephson CD
  • Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma.
    Transfusion Volume: 61 Page(s): 1740 - 1748
    06/01/2021 Authors: Verkerke H; Saeedi BJ; Boyer D; Allen JW; Owens J; Shin S; Horwath M; Patel K; Paul A; Wu S-C
  • COMPLEMENT IN THROMBOTIC MICROANGIOPATHIES
    Volume: 68 Page(s): S111 - S111
    06/01/2021 Authors: Graciaa S; Zerra P; Fasano R; Chonat S
  • CHARACTERISTICS AND OUTCOMES OF PEDIATRIC ONCOLOGY PATIENTS AT RISK FOR TRANSFUSION REFUSAL
    Volume: 68 Page(s): S97 - S98
    06/01/2021 Authors: Stevenson J; DeGroote N; Choudhury T; Keller F; Brock K; Bergsagel DJ; Miller T; Cornwell P; Chonat S; Castellino S
  • Comorbidities and complications in adults with pyruvate kinase deficiency.
    Eur J Haematol Volume: 106 Page(s): 484 - 492
    04/01/2021 Authors: Boscoe AN; Yan Y; Hedgeman E; van Beers EJ; Al-Samkari H; Barcellini W; Eber SW; Glader B; Yaish HM; Chonat S
  • Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).
    Blood Cells Mol Dis Volume: 87 Page(s): 102534
    03/01/2021 Authors: Niss O; Lorsbach RB; Berger M; Chonat S; McLemore M; Buchbinder D; McCavit T; Shaffer LG; Simpson J; Schwartz JH
  • An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.
    Immunohematology Volume: 37 Page(s): 33 - 43
    03/01/2021 Authors: Ho AD; Verkerke H; Allen JW; Saeedi BJ; Boyer D; Owens J; Shin S; Horwath M; Patel K; Paul A
  • The pyruvate kinase (PK) to hexokinase enzyme activity ratio anderythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Br J Haematol Volume: 192 Page(s): 1092 - 1096
    03/01/2021 Authors: Al-Samkari H; Addonizio K; Glader B; Morton DH; Chonat S; Thompson AA; Kuo KHM; Ravindranath Y; Wang H; Rothman JA
  • Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice.
    Blood Adv Volume: 5 Page(s): 527 - 538
    01/26/2021 Authors: Arthur CM; Allen JWL; Verkerke H; Yoo J; Jajosky RP; Girard-Pierce K; Chonat S; Zerra P; Maier C; Rha J
  • Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease.
    Clin Case Rep Volume: 9 Page(s): 457 - 460
    01/01/2021 Authors: Yee MEM; Batsuli G; Chonat S; Park S
  • Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease.
    Haematologica Volume: 105 Page(s): 2887 - 2891
    12/01/2020 Authors: Chonat S; Graciaa S; Shin HS; Newton JG; Quarmyne M-O; Boudreaux J; Tang A; Zerra PE; Rollins MR; Josephson CD
  • Role of complement in alloimmunization and hyperhemolysis.
    Curr Opin Hematol Volume: 27 Page(s): 406 - 414
    11/01/2020 Authors: Chonat S; Mener A; Verkerke H; Stowell SR
  • Characterization of the severe phenotype of pyruvate kinase deficiency.
    Am J Hematol Volume: 95 Page(s): E281 - E285
    10/01/2020 Authors: Al-Samkari H; van Beers EJ; Morton DH; Barcellini W; Eber SW; Glader B; Yaish HM; Chonat S; Kuo KHM; Kollmar N
  • Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease.
    Haematologica
    07/30/2020 Authors: Chonat S; Graciaa S; Shin HS; Newton JG; Quarmyne M-O; Boudreaux J; Tang A; Zerra PE; Rollins MR; Josephson CD
  • VOXELOTOR IN CHILDREN WITH SICKLE CELL ANEMIA: EFFICACY AND IMPROVEMENT IN ERYTHROCYTE PHYSIOLOGY
    Volume: 67 Page(s): S40 - S40
    06/01/2020 Authors: Chonat S; Fields E; Baratz H; Watt A; Pochron M; Dixon S; Tonda M; Lehrer-Graiwer J; Brown C; Archer D
  • Genotype-phenotype correlation and molecular heterogeneity in pyruvate kinase deficiency.
    Am J Hematol Volume: 95 Page(s): 472 - 482
    05/01/2020 Authors: Bianchi P; Fermo E; Lezon-Geyda K; van Beers EJ; Morton HD; Barcellini W; Glader B; Chonat S; Ravindranath Y; Newburger PE
  • Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.
    Haematologica Volume: 105 Page(s): 539 - 544
    03/01/2020 Authors: Thein SL; Pirenne F; Fasano RM; Habibi A; Bartolucci P; Chonat S; Hendrickson JE; Stowell SR
  • Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation.
    Front Immunol Volume: 11 Page(s): 905
    01/01/2020 Authors: Zerra PE; Arthur CM; Chonat S; Maier CL; Mener A; Shin S; Allen JWL; Baldwin WH; Cox C; Verkerke H
  • Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome.
    Front Pediatr Volume: 8 Page(s): 616731
    01/01/2020 Authors: Raghunandan S; Josephson CD; Verkerke H; Linam WM; Ingram TC; Zerra PE; Arthur CM; Stowell SR; Briones M; Chonat S
  • Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)
    Volume: 134
    11/13/2019 Authors: Niss O; Lorsbach RB; Buchbinder DK; Chonat S; McLemore ML; McCavit T; Schwartz JH; Meznarich J; Seu K; Zhang W
  • Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.
    Transfus Med Rev Volume: 33 Page(s): 217 - 224
    10/01/2019 Authors: Arthur CM; Chonat S; Fasano R; Yee MEM; Josephson CD; Roback JD; Stowell SR
  • MODELING COMPLEMENT-MEDIATED ACUTE LUNG INJURY IN SICKLE CELL MICE
    Volume: 114 Page(s): 496 - 496
    10/01/2019 Authors: Chonat S; Patel S; Jeffers L; Koval M; Archer D; Joiner C; Stowell S
  • Complement Mediated Hemolytic Anemia Secondary to Plasmodium ovale Infection in a Child.
    J Pediatr Hematol Oncol Volume: 41 Page(s): 557 - 558
    10/01/2019 Authors: Graciaa S; Russell R; Chonat S
  • Mechanisms of Antibody-Mediated RBC Removal: Consequences on Prevention and Treatment
    Volume: 59 Page(s): 13A - 14A
    09/01/2019 Authors: Chonat S; Arthur C; Fuller M; Jajosky R; Zerra P; Maier CL; Stowell S
  • EXTRAVASCULAR HEMOLYSIS DURING TREATMENT WITH ECULIZUMAB FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Volume: 66
    06/01/2019 Authors: Graciaa S; Chonat S
  • Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Transfus Clin Biol Volume: 26 Page(s): 130 - 134
    05/01/2019 Authors: Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R
  • Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients.
    Transfusion Volume: 59 Page(s): 1698 - 1705
    05/01/2019 Authors: Dean CL; Maier CL; Chonat S; Chang A; Carden MA; El Rassi F; McLemore ML; Stowell SR; Fasano RM
  • Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Transfus Clin Biol Volume: 26 Page(s): 94 - 98
    05/01/2019 Authors: Fasano RM; Miller MJ; Chonat S; Stowell SR
  • Chronic Alcohol Significantly Affects Pulmonary Function Both at Baseline and in Response to Endotoxemia
    Volume: 33
    04/01/2019 Authors: Jeffers LA; Smith P; Chonat S; Koval M
  • Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.
    Haematologica Volume: 104 Page(s): e51 - e53
    02/01/2019 Authors: van Beers EJ; van Straaten S; Morton DH; Barcellini W; Eber SW; Glader B; Yaish HM; Chonat S; Kwiatkowski JL; Rothman JA
  • Corrigendum: The Spectrum of SPTA1-Associated Hereditary Spherocytosis.
    Front Physiol Volume: 10 Page(s): 1331
    01/01/2019 Authors: Chonat S; Risinger M; Sakthivel H; Niss O; Rothman JA; Hsieh L; Chou ST; Kwiatkowski JL; Khandros E; Gorman MF
  • EPSTEIN-BARR VIRUS INFECTION OF T AND NK CELLS CAUSES A SEVERE AND UNUSUAL FORM OF HEMOPHAGOCYTIC LYMPHOHITICYTOSIS AMONG HISPANIC PATIENTS
    Volume: 66 Page(s): S42 - S42
    01/01/2019 Authors: Shamriz O; Bunting ST; Briones M; Chonat S; Quarmyne M-O; Chandrakasan S
  • The Spectrum of SPTA1-Associated Hereditary Spherocytosis.
    Front Physiol Volume: 10 Page(s): 815
    01/01/2019 Authors: Chonat S; Risinger M; Sakthivel H; Niss O; Rothman JA; Hsieh L; Chou ST; Kwiatkowski JL; Khandros E; Gorman MF
  • Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses.
    JCI Insight Volume: 3
    11/15/2018 Authors: Mener A; Patel SR; Arthur CM; Chonat S; Wieland A; Santhanakrishnan M; Liu J; Maier CL; Jajosky RP; Girard-Pierce K
  • Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease.
    Haematologica Volume: 103 Page(s): e483 - e485
    10/01/2018 Authors: Chonat S; Quarmyne M-O; Bennett CM; Dean CL; Joiner CH; Fasano RM; Stowell SR
  • Congenital dyserythropoietic anaemia type I diagnosed in a young adult with a history of splenectomy in childhood for presumed haemolytic anaemia.
    Br J Haematol Volume: 182 Page(s): 10
    07/01/2018 Authors: Chonat S; McLemore ML; Bunting ST; Nortman S; Zhang K; Kalfa TA
  • Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failure.
    Transfusion Volume: 58 Page(s): 1550 - 1554
    06/01/2018 Authors: Maier CL; Gross PJ; Dean CL; Chonat S; Ip A; McLemore M; El Rassi F; Stowell SR; Josephson CD; Fasano RM
  • Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
    Blood Volume: 131 Page(s): 2183 - 2192
    05/17/2018 Authors: Grace RF; Bianchi P; van Beers EJ; Eber SW; Glader B; Yaish HM; Despotovic JM; Rothman JA; Sharma M; McNaull MM
  • Hereditary xerocytosis: Diagnostic considerations.
    Am J Hematol Volume: 93 Page(s): E67 - E69
    03/01/2018 Authors: Risinger M; Glogowska E; Chonat S; Zhang K; Dagaonkar N; Joiner CH; Quinn CT; Kalfa TA; Gallagher PG
  • Alu element insertion in PKLR gene as a novel cause of pyruvate kinase deficiency in Middle Eastern patients.
    Hum Mutat Volume: 39 Page(s): 389 - 393
    03/01/2018 Authors: Lesmana H; Dyer L; Li X; Denton J; Griffiths J; Chonat S; Seu KG; Heeney MM; Zhang K; Hopkin RJ
  • Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.
    Blood Adv Volume: 2 Page(s): 105 - 115
    01/23/2018 Authors: Patel SR; Bennett A; Girard-Pierce K; Maier CL; Chonat S; Arthur CM; Zerra PE; Mener A; Stowell SR
  • Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion.
    Front Immunol Volume: 9 Page(s): 2516
    01/01/2018 Authors: Patel SR; Gibb DR; Girard-Pierce K; Zhou X; Rodrigues LC; Arthur CM; Bennett AL; Jajosky RP; Fuller M; Maier CL
  • Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion.
    Blood Volume: 130 Page(s): 2654 - 2663
    12/14/2017 Authors: Carden MA; Fay ME; Lu X; Mannino RG; Sakurai Y; Ciciliano JC; Hansen CE; Chonat S; Joiner CH; Wood DK
  • The First Registry for Patients with Congenital Dyserythropoietic Anemia in North America: Design and Preliminary Results
    Volume: 130
    12/07/2017 Authors: Niss O; Lorsbach RB; Christakopoulos GE; Trump L; Reynolds M; Giger K; Johnson CE; Husami A; Buchbinder DK; Rothman JA
  • Primed CD4 T Cells to an Intracellular Alloantigen Facilitate Alloimmunization Following Subsequent Transfusion
    Volume: 130
    12/07/2017 Authors: Patel SR; Bennett AL; Zerra PE; Chonat S; Maier C; Stowell SR
  • Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.
    Volume: 1013 Page(s): 59 - 87
    01/01/2017 Authors: Chonat S; Quinn CT
  • Reactive Oxygen Species Produced by NADPH Oxidase Contribute to Cardiac Pathology in a Mouse Model of Sickle Cell Disease
    Volume: 128
    12/02/2016 Authors: Christakopoulos GE; Chonat S; Valiente-Alandi I; Konstantinidis DG; Schleper A; Bakeer N; Loberg A; Blaxall BC; Zheng Y; James J
  • Cellular Hydration and Oxidation As Phenotype Modifiers in Sickle Cell Anemia
    Volume: 128
    12/02/2016 Authors: Risinger MA; Dagaonkar N; Christakopoulos GE; Liu J; Seu KG; Konstantinidis DG; Quinn CT; Chonat S; Joiner CH; Zhang K
  • Atypical haemolytic uraemic syndrome in a patient with sickle cell disease, successfully treated with eculizumab.
    Br J Haematol Volume: 175 Page(s): 744 - 747
    11/01/2016 Authors: Chonat S; Chandrakasan S; Kalinyak KA; Ingala D; Gruppo R; Kalfa TA
  • Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.
    Blood Cells Mol Dis Volume: 61 Page(s): 4 - 9
    10/01/2016 Authors: Niss O; Chonat S; Dagaonkar N; Almansoori MO; Kerr K; Rogers ZR; McGann PT; Quarmyne M-O; Risinger M; Zhang K
  • The Spectrum of Alpha-Spectrin Associated Hereditary Spherocytosis
    Volume: 126
    12/03/2015 Authors: Chonat S; Risinger M; Dagaonkar N; Maghathe T; Rothman J; Connor J; Kalinyak K; Begtrup AH; Zhang K; Kalfa TA
  • Alu-Element Insertion in Pklr Gene As a Novel Cause of Severe Hereditary Nonspherocytic Hemolytic Anemia
    Volume: 126
    12/03/2015 Authors: Lesmana H; Dyer L; Zhou P; Li X; Denton J; Chonat S; Zhang K; Hopkin RJ; Kalfa TA
  • Complement mutations as disease modifier in paroxysmal nocturnal hemoglobinuria
    Volume: 67 Page(s): 135 - 136
    09/01/2015 Authors: Dixon B; Chonat S; Palumbo J
  • Cation Leak in Red Blood Cells of Patients with Wiskott-Aldrich Syndrome Leads to Non-Immunologic Hemolysis
    Volume: 124
    12/06/2014 Authors: Sokolic RA; Chonat S; Risinger M; Eckhaus M; Garabedian E; Calvo KR; Maric I; Kalfa TA; Candotti F
  • AUTOSOMAL RECESSIVE HEREDITARY SPHEROCYTOSIS IN PATIENTS WITH THE C.4339-99C> T alpha LEPRA MUTATION IN THE SPTA1 GENE
    PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S16 - S17
    05/01/2014 Authors: Connor J; Dagaonkar N; Chonat S; Keddache M; Zhang K; Begtrup A; Kalfa T; Dexheimer P
  • HEREDITARY SPHEROCYTOSIS DUE TO BIALLELIC OR MONOALLELIC ANKYRIN MUTATIONS
    PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S70 - S70
    05/01/2014 Authors: Chonat S; Dagaonkar N; Maghathe T; Connor J; Mullins E; Zhang K; Kalfa T
  • CHILDHOOD OPTIC NERVE SHEATH MENINGIOMAS
    PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S70 - S70
    05/01/2014 Authors: Chonat S; Salloum R; Breneman J; Gray M; Koch B; Fouladi M
  • ECULIZUMAB TREATMENT OF THROMBOTIC MICROANGIOPATHY (TMA) IN SICKLE CELL DISEASE
    PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S38 - S38
    05/01/2014 Authors: Chonat S; Chandrakasan S; Kalinyak K; Ingala D; Gruppo R; Kalfa T
  • DEVELOPMENT OF A COMPREHENSIVE RAPID NEXT-GENERATION SEQUENCING ASSAY FOR THE DIAGNOSIS OF INHERITED HEMOLYTIC ANEMIA
    PEDIATRIC BLOOD & CANCER Volume: 61 Page(s): S59 - S60
    05/01/2014 Authors: Begtrup AH; Dagaonkar N; Chonat S; Giger K; Husami A; Kissell D; Risinger M; Joiner C; Keddache M; Zhang K
  • Absent left common and left external iliac artery presenting in a neonate.
    J Perinatol Volume: 33 Page(s): 407 - 409
    05/01/2013 Authors: Patel M; Chonat S; Olomu I; Arrington S; Kadrofske M
  • Cutaneous lesions in transient abnormal myelopoiesis.
    J Paediatr Child Health Volume: 48 Page(s): 184 - 185
    02/01/2012 Authors: Winckworth LC; Chonat S; Uthaya S
  • CUTANEOUS LESIONS IN TRANSIENT ABNORMAL MYELOPOIESIS
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH Volume: 48
    02/01/2012 Authors: Winckworth LC; Chonat S; Uthaya S
  • Adolescent hematology
    Page(s): 137 - 170
    01/01/2012 Authors: Gera R; Saah EZ; Pawar A; Chonat S; Scott-Emuakpor AB; Kulkarni R
  • Co-occurrence of Chiari malformations and sickle cell disease-a diagnostic dilemma: a report of 4 cases and review of literature.
    J Pediatr Hematol Oncol Volume: 33 Page(s): 624 - 625
    12/01/2011 Authors: Chonat S; Saah E; Gera R; Scott-Emuakpor A; Kulkarni R
  • Nutritional outcomes in surgical neonates after hospital discharge.
    Pediatr Surg Int Volume: 27 Page(s): 553 - 554
    05/01/2011 Authors: Winckworth LC; Chonat S; Chuang S-L
  • NUTRITIONAL OUTCOME OF SURGICAL NEONATES AFTER HOSPITAL DISCHARGE
    PEDIATRIC RESEARCH Volume: 68 Page(s): 533 - 534
    11/01/2010 Authors: Chuang S-L; Winckworth L; Chonat S; Santhoush P; Harley C; Ogundipe E
  • WERNICKE'S-LIKE ENCEPHALOPATHY AND GENERALIZED ENCEPHALOPATHY FOLLOWING TREATMENT IN MEDULLOBLASTOMA
    PEDIATRIC BLOOD & CANCER Volume: 54 Page(s): 856 - 856
    06/01/2010 Authors: Chonat S; Saah E; Gera R; Scott-Emuakpor A; Kulkarni R
  • NUTRITIONAL FOLLOW-UP IN SURGICAL NEONATES AFTER HOSPITAL DISCHARGE
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION Volume: 50 Page(s): E175 - E175
    06/01/2010 Authors: Chuang S; Winckworth L; Chonat S; Harley C; Ogundipe E
  • Use of premedication for intubation in tertiary neonatal units in the United Kingdom.
    Paediatr Anaesth Volume: 19 Page(s): 653 - 658
    07/01/2009 Authors: Chaudhary R; Chonat S; Gowda H; Clarke P; Curley A
  • A rare case of fatal infantile juvenile systemic xanthogranuloma
    Volume: 159 Page(s): 120 - 121
    07/01/2008 Authors: Hafiji J; Wimalendra M; Chonat S; Hook E; Burke A; Burrows NP
  • Use of pre-medication before intubation in tertiary neonatal units in the United Kingdom
    ACTA PAEDIATRICA Volume: 96 Page(s): 98 - 98
    10/01/2007 Authors: Chonat S; Chaudhary R; Gowda H; Clarke P; Curley A
  • Variations in practice among paediatric consultants when referring unexpected neonatal deaths to a coroner.
    Arch Dis Child Fetal Neonatal Ed Volume: 92 Page(s): F234
    05/01/2007 Authors: Chonat S; Lakshman R; Clements M; Iles R
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements